CoRegen, Inc.
BiotechnologyBiopharmaceuticals
Aspen, CO
2022
founded
About
CoRegen, Inc. is a pioneering biopharmaceutical company dedicated to the development of innovative treatments aimed at aggressive cancers and chronic diseases. Utilizing its proprietary master gene regulator platform, CoRegen works on harnessing the body’s immune system to combat cancer effectively.
Company Values
CoRegen stands out by deploying a unique strategy of targeting multiple immune checkpoint genes simultaneously, which promotes robust anti-tumor effects that may surpass traditional therapies.